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Abstract
High accuracy of blood glucose prediction over the
long term is essential for preventative diabetes
management. The emerging closed-loop insulin delivery
system such as the artificial pancreas system (APS)
provides opportunities for improved glycaemic control
for patients with type 1 diabetes. Existing blood glucose
studies are proven effective only within 30 minutes but
the accuracy deteriorates drastically when the
prediction horizon increases to 45 minutes and 60
minutes. Deep learning, especially for long short term
memory (LSTM) and its variants have recently been
applied in various areas to achieve state-of-the-art
results in tasks with complex time series data. In this
study, we present deep LSTM based models that are
capable of forecasting long term blood glucose levels
with improved prediction and clinical accuracy. We
evaluate our approach using 20 cases(878,000 glucose
values) from Open Source Artificial Pancreas System
(OpenAPS). On 30-minutes and 45-minutes prediction,
our Stacked-LSTM achieved the best performance with
Root-Mean-Square-Error (RMSE) marks 11.96 & 15.81
and Clark-Grid-ZoneA marks 0.887 & 0.784. In terms
of 60-minutes prediction, our ConvLSTM has the best
performance with RMSE = 19.6 and Clark-GridZoneA=0.714. Our models outperform existing methods
in both prediction and clinical accuracy. This research
can hopefully support patients with type 1 diabetes to
better manage their behavior in a more preventative
way and can be used in future real APS context.
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destroyed, preventing the body from being able to
produce enough insulin to adequately regulate blood
glucose levels [1]. Estimating and predicting blood
glucose in both the short-term and long-term are
essential for effective management of diabetes. The
traditional approach to managing Type 1 diabetes relies
on patients’ own estimation of insulin amount which
often leads to hyperglycemia or hypoglycemia due to
incorrect estimation [2]. The artificial pancreas, or
closed-loop insulin delivery system is emerging to
continuously monitors blood sugar levels, calculates the
amount of insulin required (through a device such as a
tablet or mobile phone), and automatically delivers
insulin through a pump [3]. Although the insulin pump
automatically adjusts basal insulin in existing FDA
approved hybrid closed-loop system [4], accurate
prediction on long-term blood glucose level under the
context of closed-loop artificial pancreas system (APS)
is of high importance because it is essential for
preventative blood glucose control and to better guide
meals intake, exercise and support patients planning
daily activities further ahead (e.g. 1 hour). This will
allow patients to take actions ahead of time in order to
the occurrence of adverse glycaemic events.
Existing blood glucose prediction research focuses on
short term predictions such as 15 minutes to 30 minutes
but the performance of the prediction models dropped
dramatically when it comes to long term predictions
such as 45 min to 1 hour [5]. The state-of-the-art deep
learning models such as long short term memory
(LSTM) and its variants demonstrate strong capabilities
in long term forecasting [6]. In this research, we aim to
develop a long-term blood glucose forecasting model
based on convolutional-LSTM and compare our model
with other LSTM models and existing methods used in
blood glucose prediction.

1. Introduction
Type 1 Diabetes is an autoimmune disease that causes
the insulin-producing beta cells in the pancreas to be
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Figure 1 Artificial Pancreas System
The remainder of this article is structured as follows.
The related works are presented in Section 2, variations
of LSTM are introduced in Section 3, dataset and
training process are in Section 4, evaluation methods in
Section 5, comments on results in Section 6, and
conclusions in Section 7.

2. Blood glucose prediction research
Blood glucose prediction research range from
physiological, data-driven and hybrid approach [10].
The physiological approach relies on expert knowledge
on insulin and glucose metabolism focusing on
simulation models [11, 12, 13]. The main challenge of
physiological models is the lack of generalization
capability and need support from data for higher
prediction performance. Data-driven approaches are
mainly based on machine learning methods such as
fuzzy logic and rule-based models [14], multi-modal
approaches [15, 16] autoregressive models [17, 18],
support vector machine [19] and artificial neural
networks models [20]. The hybrid approach includes
physiological models such as glucose digestion and
absorption, insulin absorptions, exercise, and other
events. Those physiological models pre-process related
data and the results are used in a data-driven model. [21,
22, 23].
Although there are existing studies on blood glucose
prediction, the accuracy of longer-term accuracy
remains the main challenge for blood glucose prediction
studies [4]. Prediction horizon (PH) has been used in the
vast majority of the studies for evaluation processes.
Existing studies show an increase in the PH leads to a
deterioration in the accuracy of a given model [4].
However, PH is important to be considered because
patients’ needs in deciding meals, physical activity, and
other events happen over time. Therefore, both accuracy

and PH need to be considered to best meet patients’
needs. However, existing research can only demonstrate
high performance in 30 min PH but cannot meet the
accuracy requirement for glycaemic control for a longer
period. Therefore a 30 min PH is the most common
value for blood glucose prediction but high accuracy in
longer PH is needed.
Deep learning, which incorporates methods recently
proved to outperform the already established
methodologies [24]. It has led to significant progress in
computer vision [25], disease diagnosis [26], and
healthcare [27, 28]. Deep learning shows superior
performance to traditional ML techniques due to this
ability to automatically learn features with higher
complexity and representations [29-32]. Recurrent
Neural Networks (RNNs) have shown its capability in
many applications with time series or sequential data,
including machine translation [33, 34] and speech
recognition [35]. One of the major challenges in
designing systems using classical RNNs is their limited
capacity to learn long-term dependencies, because of the
vanishing or exploding gradient problem [36]. Recent
deep RNNs incorporate mechanisms to address this
problem [37], e.g. long-short-term memory (LSTM)
which introduces the memory cell and forget gate into
classical RNN network [38]. Furthermore, the state-ofthe-art LSTM variants such as bidirectional LSTM (BiLSTM) [39], vanilla LSTM (V-LSTM) [40], stacked
LSTM [41], convolutional LSTM (c-LSTM) [42] and
convolutional neural network LSTM (CNN) [43] have
shown more promising results for time series
predictions [6] because of their capability of capturing
rich information from complex time series data. In this
research, we propose a deep learning blood glucose
prediction model based on LSTM variants for improved
prediction and clinical accuracy.

3. LSTM variants based model for longterm blood glucose forecasting
3.1 LSTM
Long short-term memory(LSTM) is a special kind of
recurrent neural network architecture(RNN). It is widely
used on problems based on time series data such as
speech recognition, handwriting recognition, prediction
in healthcare pathways, etc. Unlike ordinary RNN,
LSTM is specialized at manipulating Long-Term
dependencies because it employs the “remember”
mechanism through a series of gates. This feature fits
the scenario of the glucose prediction problem because
the observation window could be quite long which
makes other machine learning methods difficult to
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handle. The equations for the forward pass of the LSTM
unit are as follows.

outputs a sequence of vectors that will be used as the
input of the subsequent LSTM layer.

where the subscript t indexes the time step, the
operator∘denotes the element-wise product.
𝑥𝑡 : input vector to the LSTM unit
𝑓𝑡 : forget gate's activation vector
𝑖𝑡 : input/update gate's activation vector
𝑜𝑡 : output gate's activation vector
ℎ𝑡 : hidden state vector also known as output vector of
the LSTM unit
𝑐𝑡 : cell state vector
W, U: weight matrices for input vectors and hidden
vectors
b: bias vector parameters
The architecture of the vanilla LSTM for glucose
prediction is illustrated in Figure 2, a sequence of
glucose values are input into the RNN-LSTM network
and the target value is predicted at the end of the
sequence.

Figure 3 Stacked LSTM

3.3 CNN-LSTM
Due to the intensity of glucose data, we employ CNN in
order to better represent the latent features in the glucose
series, combined with LSTM we have CNN-LSTM.
CNN-LSTM is the combination of CNN layers and
LSTM layers in order to take both advantages of CNN
and LSTM. It is first designed for spatial inputs
prediction problems like image sequence and video
sequence prediction, recently it also has been applied in
general time series prediction problems and acquired
promising results. The architecture of CNN-LSTM as
illustrated in Figure 4 includes Convolutional Neural
Network(CNN) layers on feature extraction, a follow-up
Max Pooling Layer for summarizing the most activated
presence of a feature, then a pile of LSTM layers to
handle the sequence processing and finally a FullyConnected Layer before the output.

Figure 2 Vanilla LSTM

3.2 Stacked LSTM
The success of deep neural networks attributes to its
application of multiple layers. Each layer solves part of
the task and altogether the complex network increases
the representation power. We can also apply the same
strategy on LSTM by adding more layers to make it
deeper. The outcome of this idea is the so-called
stacked-LSTM. As the name implies, it is an extension
of the vanilla LSTM network by stacking a sequence of
LSTM layers. Figure 2 gives the architecture of
stacked-LSTM,
which
has
several
LSTM
layers(vertically). In operation, each LSTM layer

Figure 4 CNN-LSTM

3.4 ConvLSTM
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ConvLSTM is another way to leverage both CNN and
LSTM. Instead of putting a CNN layer before the LSTM
layer, ConvLSTM modifies the internal computation
logic and convolution operation in the LSTM cell. In
running time, ConvLSTM first read the input with the
convolutional part and feed the output into each LSTM
unit. The most obvious part exchanged in ConvLSTM is
that
convolution
operations
replace
matrix
multiplication. So we have, e.g. the forget gate becomes
, where '*'
denotes convolution. Other formulas listed in Section
3.1 are updated in the same way.
The structure of ConvLSTM presents as follows:

Figure 5 ConvLSTM
The structure looks similar to vanilla LSTM except that
the cells are replaced by ConvLSTM cells and the
sequence is chunked and shaped to 3 dimensions to meet
the needs of convolution calculation.

4. Data and training
The data in this paper comes from donated CGM data
of the OpenAPS project [7,8,9]. The glucose values are
recorded every 5 minutes. We selected twenty persons'
datasets from youth and adult age groups respectively
which have the most integrity in one period. The overall
number of time points is 878k, of which 1/3 are reserved
as test data. Regarding the setting of the training and
target window, we consulted clinicians about their
practice in evaluating patients' glucose history and make
a decision as follows: The training sliding window sizes
are 60 minutes and 120 minutes respectively as they
demonstrated better performance than other window
sizes. So the input represented with time steps is 12 and
24. The prediction horizons are 30 minutes, 45 minutes
and 60 minutes respectively. That gives the output
length is 6, 9 and 12. There are limited missing values
in the datasets, we filled them with linear interpolation
The hardware for the training task includes 1 x
NVIDIA Tesla V100 and 4vCPU 26G memory, e.g.
The software that we used includes Pandas for data
wrangling and Keras-LSTM library for training, the
batch size is 128, the number of epochs is 100.

5 Evaluation
We evaluate the results from two perspectives. One is
the statistical evaluation which we use root-meansquared-error(RMSE) to evaluate the prediction ability
of the model. Another is the clinical accuracy
evaluation which we employ the Clarke error analysis.
RMSE is the square root of the average squared
difference between predicted values and the actual
values. In general, the lower this value means a better
average prediction performance. The RMSE formation
can be illustrated as follows:

where 𝑦𝑘 is the actual value and 𝑦̂𝑘 is the predicted one.
Although RMSE is widely used in the evaluation of time
series prediction, it takes each value equally and only
looks at the value difference. However, in medical
practice like glucose management, different values may
have significant difference in clinician outcome. Thus
we introduce Clarke Error Grid analysis which pays
more attention to the medical significance and amplify
the prediction errors that could lead to risk treatments.
As shown in figure 6, 7 and 8 of the error grids, the
horizontal axis represents true blood glucose and the
vertical axis represents predicted blood glucose by the
model. Specifically, breaks down the true-predicted
blood glucose value scatter plots into five clinical
meaningful regions. The regions signify the degree of
risk posed by the incorrect prediction.
● Section A. Predicted blood glucose value is within
20% of the actual blood glucose values. This means the
prediction error has no effect on clinical action therefore
these points are also called clinical accurate ones which
are appropriate to lead to the interventions.
● Section B. Predicted value is beyond 20% but would
not lead to inappropriate treatment. The prediction error
has little or no effect on clinical outcomes.
● Section C. The points in this area indicate the
prediction errors might indicate an unnecessary
treatment.
● Section D. The points in this area means the prediction
errors will lead to a dangerous failure of detecting
hypoglycemia and hyperglycemia
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● Section E. The points in this area means the prediction
error could lead to dangerous consequences and it will
confuse the treatment of hypoglycemia and
hyperglycemia.
Of all the 5 sections, the percentage of A+B states how
the prediction algorithm performs in a clinical
acceptance way, while we should also be aware of C, D,
and E which symbolizes the errors that may lead to miss
judgment in treatments. More percentage in A means
less errors thus more clinically accurate predictions.

In addition to prediction accuracy, we also evaluated the
clinical accuracy using the Clarke Error analysis to
understand the clinical value of the proposed methods.
Table 2 shows the score of Clarke zone A and zone B of
CNN, v-LSTM, bi-LSTM, s-LSTM, CNN-LSTM,
convLSTM and SVR over 30 minutes, 45 minutes and
60 minutes prediction horizon.
Table 2 The Clinical Accuracy from Clarke Error
Analysis
Method\
PH(min)

30 min

45 min

60 min

6. Results
Azo
ne

Bzon
e

Azone

Bzon
e

Azone

Bzone

CNN

0.84
4

0.124

0.732

0.230

0.652

0.304

vanillaLSTM

0.87
1

0.108

0.782

0.182

0.650

0.309

stackedLSTM

0.88
7

0.089

0.784

0.181

0.700

0.250

CNNLSTM

0.86
1

0.110

0.748

0.214

0.700

0.257

convLST
M

0.86
8

0.102

0.782

0.182

0.713

0.245

SVR

0.80
4

0.107

0.703

0.180

0.645

0.213

6.1 Prediction accuracy in RMSE
We compared the performance among LSTM variants
based models and support vector regression (SVR)
method as the baseline. Table 1 shows the blood glucose
prediction accuracy of CNN, v-LSTM, CNN-LSTM
convLSTM and SVR over the prediction horizon of 30,
45 and 60 minutes. We notice that stacked-LSTM gives
the best RMSE performance under the short-term(30
minutes) and mid-term(45 minutes) horizon. VanillaLSTM has the lowest score on long-term(60 minutes)
horizon prediction. However, vanilla-LSTM only
outperforms stacked-LSTM with 0.1 difference(19.01
vs 19.24) .If we consider the overall performance on all
prediction horizons, stacked-LSTM achieves the best
score. Besides, all the LSTM variant models outperform
SVR in 30, 45 and 60 prediction horizons.
Table 1 Blood Glucose Prediction Accuracy
comparison in RMSE
Method\PH(
min)

30 min

45 min

60 min

CNN

14.74±1.06

18.08±1.94

21.04±2.45

vanillaLSTM

12.33±1.15

15.86±1.80

19.01±2.62

stackedLSTM

11.96±1.02

15.81±1.56

19.24±1.78

CNN-LSTM

13.05±1.21

16.72±2.28

19.80±2.54

convLSTM

12.20±0.94

15.82±1.85

19.60±2.01

SVR

13.28±1.02

17.89±1.34

24.21±2.96

6.2 Clinical Accuracy

We can learn that all methods have a high clinical
acceptance rate because the total score of zone A and B
for each LSTM variant based model has an average
above 0.95. When we look at the long term prediction
accuracy, convLSTM gives the best performance with
zone A score of 0.713 in 60 minutes prediction horizon.
Stacked-LSTM shows the best performance in 30 and
45 minutes prediction horizons with Clarke zone A
score of 0.887 and 0.784 respectively. Figure 6-8
illustrates points distribution of the best prediction on
Clarke Grid Analysis on 60 minutes, 45 minutes, and 30
minutes prediction horizons respectively. It’s clear that
the majority of points spread in ZoneA+B which is good
to lead the treatment. When we look at Zone C-D,
compared with zone-C, points zone-D develops fast as
the target horizon increases from 30 minutes to 60
minutes. It indicates that the failure of detecting
hypoglycemia and hyperglycemia increases as we
predict farther in the future. That is one potential
orientation for optimization.
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7. Conclusion

Figure 6 Clarke Error of convLSTM on PH 60(min)

Figure 7 Clarke Error of Stacked LSTM on PH
45(min)

Figure 8 Clarke Error of Stacked LSTM on PH
30(min)

In this paper, we developed LSTM variants based blood
glucose prediction models for improved prediction and
clinical accuracy in long prediction horizon. The
modified LSTM can capture more long-term
dependencies due to deeper architecture and learn to
remove background noise, outline important features
and better captures both future and past context of the
input sequence. We evaluate the prediction and clinical
accuracy of the long term (above 30 minutes) of the
proposed methods using 20 cases of real-life data from
OpenAPS community. Prediction results were
compared between LSTM variants and to those
established learning algorithms and widely used
algorithms applied to the real-time prediction of glucose
using CGM data. Prediction Horizons (PH) of 30, 45,
and 60 minutes were used. The proposed LSTM variant
based methods showed superior performance in
forecasting BG levels (RMSE and clinical accuracy)
against existing methods. For several other works, it is
difficult to evaluate the RMSE through direct
comparison due to the availability of benchmark
datasets. However, we may compare the results with
widely used methods as benchmarks, such as SVR. The
results show that our approach suggests superiority in
their prediction accuracy over the 30, 45, and 60 minute
time period than existing studies [43][46]. As far as we
know, the proposed algorithm achieves a performance
state-of-the-art accuracy with regard to RMSE and
clinical accuracy.
There are several limitations and future work for this
research. First, the longest prediction horizon evaluated
is 60 minutes and future work will further improve the
proposed models for longer term prediction towards
more than 4 hours. Second, future life events will be
considered over the longer prediction horizons to
improve the performance. A hybrid model combining
the advantages of both physiological and LSTM based
approach could be developed. Thirdly, there is timing
effects that users of OpenAPS have DIY systems
making insulin dosing adjustments and acting upon
them so it will affect the prediction results. We will
consider quantify these influences and make the
prediction more accurate. Although some works suggest
that ingested carbohydrate information, along with
injected insulin information might be redundant [44,
45], we will in future incorporate more clinical
information such as comorbidities and other information
from Electronic Patient Record for detailed patients
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phenotyping and personalized prediction model
development. Finally, we have demonstrated the
application of deep learning based blood glucose
prediction model in the real-life data but more data from
both OpenAPS and patients under various closed-loop
system could reflect a wider population.
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